Concepedia

Quentin Van Thillo

QV

4

Publications

103

Citations

4

H-Index

2020

Active since

Affiliations

KU Leuven(Current)

Universitair Ziekenhuis Leuven

VIB-KU Leuven Center for Cancer Biology

Rega Institute for Medical Research

Hasselt University

Quentin Van Thillo is an author at KU Leuven specializing in tumor biology, immunology, and gene expression.

ORCID

Top concepts

Publications per year

2020–2022

4

Publications

4

Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma

Timothy Devos, Quentin Van Thillo, Veerle Compernolle et al. · European Respiratory Journal · 2021 · 48 citations · Full text

Oncogenic cooperation between TCF7-SPI1 and NRAS(G12D) requires β-catenin activity to drive T-cell acute lymphoblastic leukemia

Quentin Van Thillo, Jolien De Bie, Janith A. Seneviratne et al. · Nature Communications · 2021 · 20 citations · Full text

A randomized, open-label, adaptive, proof-of-concept clinical trial of modulation of host thromboinflammatory response in patients with COVID-19: the DAWn-Antico study

Thomas Vanassche, Matthias M. Engelen, Quentin Van Thillo et al. · Trials · 2020 · 18 citations · Full text

Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma

Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer et al. · Blood · 2022 · 17 citations · Full text

, , +12

Rows per page

1–4 of 4